Squarepoint
IDXX icon

Squarepoint’s Idexx Laboratories IDXX Stock Holding History

Squarepoint’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,400
Closed -$2.17M – 4541
2025
Q3 		$2.17M Buy
3,400
+2,100
+162% +$1.27M ﹤0.01% 2027
2025
Q2 		$697K Buy
+1,300
New +$622K ﹤0.01% 2980
2024
Q2 		– Sell
-5,100
Closed -$2.75M – 4335
2024
Q1 		$2.75M Buy
+5,100
New +$2.79M ﹤0.01% 1889

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Squarepoint's IDXX Position: Q1 2026 in Review

Squarepoint increased its Idexx Laboratories (IDXX) stake by 75% in Q1 2026, buying an estimated $27.5M and bringing the position to 100,309 shares worth $56.4M. The position accounts for 0.07% of the portfolio, ranked #301.

Squarepoint first reported a position in IDXX in Q1 2015 and has held it in 34 quarters since. The position peaked at $92.6M in Q2 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Squarepoint held 100,309 shares of Idexx Laboratories worth $56.4M as of Q1 2026.
  • Squarepoint bought 42,885 Idexx Laboratories shares in Q1 2026, an estimated $27.5M.
  • Idexx Laboratories made up 0.07% of Squarepoint's portfolio in Q1 2026, its #301 holding.
  • Squarepoint first reported a position in Idexx Laboratories in Q1 2015 and has held it in 34 quarters since.
  • Squarepoint's Idexx Laboratories position peaked at $92.6M in Q2 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.